1 study found for:    NCT01623349
Show Display Options
Rank Status Study
1 Recruiting Phase I of BKM120/Olaparib for Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer
Conditions: Ovarian Cancer;   Breast Cancer
Intervention: Drug: BKM120 and Olaparib

Indicates status has not been verified in more than two years